tiprankstipranks
Selectis Health (GBCS)
OTHER OTC:GBCS
US Market
Want to see GBCS full AI Analyst Report?

Selectis Health (GBCS) Ratios

4 Followers

Selectis Health Ratios

GBCS's free cash flow for Q1 2026 was $0.00. For the 2026 fiscal year, GBCS's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.60 0.30 0.18 0.27 0.72
Quick Ratio
0.60 0.30 0.18 0.27 0.72
Cash Ratio
0.08 0.04 0.03 0.08 0.21
Solvency Ratio
0.24 0.01 -0.02 -0.05 -0.01
Operating Cash Flow Ratio
-0.09 0.07 -0.09 0.03 -0.04
Short-Term Operating Cash Flow Coverage
0.00 0.16 -0.14 0.04 -0.10
Net Current Asset Value
$ -19.93M$ -31.21M$ -35.33M$ -38.68M$ -36.57M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.78 0.96 0.92 0.89
Debt-to-Equity Ratio
0.00 -4.10 -5.96 -12.57 39.76
Debt-to-Capital Ratio
0.00 1.32 1.20 1.09 0.98
Long-Term Debt-to-Capital Ratio
0.00 1.86 1.39 1.13 0.97
Financial Leverage Ratio
116.17 -5.25 -6.18 -13.72 44.59
Debt Service Coverage Ratio
0.12 0.16 0.08 -0.51 0.28
Interest Coverage Ratio
-1.14 -0.91 -1.33 -4.12 -0.13
Debt to Market Cap
0.00 3.72 9.47 2.84 2.63
Interest Debt Per Share
0.69 8.86 11.31 12.90 13.30
Net Debt to EBITDA
-1.91 11.18 26.45 -4.90 24.21
Profitability Margins
Gross Profit Margin
15.11%16.25%23.13%14.70%26.45%
EBIT Margin
2.16%1.72%-0.95%-24.36%-0.71%
EBITDA Margin
1.76%5.27%3.02%-19.83%3.71%
Operating Profit Margin
-6.29%-3.78%-6.91%-24.36%-0.71%
Pretax Profit Margin
17.20%-2.45%-6.14%-10.80%-5.90%
Net Profit Margin
16.11%-2.45%-6.14%-10.80%-5.90%
Continuous Operations Profit Margin
16.11%-2.45%-6.14%-10.80%-5.90%
Net Income Per EBT
93.64%100.08%100.00%100.00%100.00%
EBT Per EBIT
-273.46%64.87%88.82%44.32%834.84%
Return on Assets (ROA)
20.52%-3.12%-7.25%-9.76%-5.64%
Return on Equity (ROE)
-136.86%16.36%44.80%133.98%-251.46%
Return on Capital Employed (ROCE)
-17.56%-21.42%-19.75%-39.78%-0.81%
Return on Invested Capital (ROIC)
-16.47%-8.09%-10.18%-25.90%-0.74%
Return on Tangible Assets
20.78%-3.22%-7.49%-10.03%-5.79%
Earnings Yield
67.61%-14.85%-71.43%-30.23%-16.76%
Efficiency Ratios
Receivables Turnover
15.36 17.26 15.09 17.59 13.98
Payables Turnover
0.00 5.52 4.62 5.19 8.19
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
2.09 1.80 1.40 1.09 1.15
Asset Turnover
1.27 1.27 1.18 0.90 0.96
Working Capital Turnover Ratio
-3.16 -2.45 -2.70 -4.88 -14.24
Cash Conversion Cycle
23.76 -45.01 -54.85 -49.57 -18.43
Days of Sales Outstanding
23.76 21.14 24.19 20.75 26.11
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 66.15 79.04 70.33 44.54
Operating Cycle
23.76 21.14 24.19 20.75 26.11
Cash Flow Ratios
Operating Cash Flow Per Share
-0.47 0.61 -0.60 0.18 -0.10
Free Cash Flow Per Share
-0.42 0.47 -0.61 0.17 -0.17
CapEx Per Share
0.05 0.14 0.01 <0.01 0.07
Free Cash Flow to Operating Cash Flow
0.89 0.76 1.02 0.94 1.73
Dividend Paid and CapEx Coverage Ratio
-5.91 4.23 -31.15 14.62 -1.21
Capital Expenditure Coverage Ratio
-8.87 4.24 -50.59 18.01 -1.37
Operating Cash Flow Coverage Ratio
0.00 0.07 -0.06 0.01 >-0.01
Operating Cash Flow to Sales Ratio
-0.04 0.05 -0.05 0.01 >-0.01
Free Cash Flow Yield
-14.06%21.03%-54.82%3.86%-3.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
1.48 -6.73 -1.40 -3.31 -5.97
Price-to-Sales (P/S) Ratio
0.24 0.17 0.09 0.36 0.35
Price-to-Book (P/B) Ratio
35.26 -1.10 -0.63 -4.43 15.00
Price-to-Free Cash Flow (P/FCF) Ratio
-7.11 4.75 -1.82 25.92 -27.10
Price-to-Operating Cash Flow Ratio
-6.31 3.63 -1.86 24.48 -46.85
Price-to-Earnings Growth (PEG) Ratio
<0.01 0.12 0.04 -0.05 1.63
Price-to-Fair Value
35.26 -1.10 -0.63 -4.43 15.00
Enterprise Value Multiple
11.62 14.31 29.29 -6.70 33.71
Enterprise Value
7.82M 31.27M 34.94M 48.90M 50.76M
EV to EBITDA
11.62 14.31 29.29 -6.70 33.71
EV to Sales
0.20 0.75 0.88 1.33 1.25
EV to Free Cash Flow
-6.11 21.74 -18.78 96.47 -96.23
EV to Operating Cash Flow
-5.42 16.62 -19.15 91.12 -166.35
Tangible Book Value Per Share
-0.04 -2.38 -2.14 -1.32 -0.04
Shareholders’ Equity Per Share
0.08 -2.02 -1.79 -0.97 0.32
Tax and Other Ratios
Effective Tax Rate
0.06 >-0.01 0.00 0.00 0.00
Revenue Per Share
12.47 13.51 13.03 12.04 13.46
Net Income Per Share
2.01 -0.33 -0.80 -1.30 -0.79
Tax Burden
0.94 1.00 1.00 1.00 1.00
Interest Burden
7.98 -1.43 6.43 0.44 8.35
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.23 0.21 0.23 0.27 0.19
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 0.00
Income Quality
-0.23 -1.85 0.75 -0.14 0.13
Currency in USD